Clinical Trial Update: Bevacizumab With or Without Surgery for Adult Glioblastomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with or without surgery for adult glioblastomas was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Glioblastoma

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Glioblastoma, Brain Neoplasm | Phase 2 | Status: WITHDRAWN